Last Friday, your voice was heard in Congress. Thanks to your activism, the provision to expand the Federal Trade Commission’s powers—and with it, the likely restricted access to nutritional supplements—did not make it into the final Wall Street “Reform” bill.
The “Wall Street Reform and Consumer Protection Act” is now in conference committee, the conferees have been named, and meetings have begun. We still have an opportunity to make sure the Waxman amendment threatening supplements doesn’t end up in the final version of the bill—if we act quickly.
This week we answer questions about drug company contributions to senate campaigns, and learn that sometimes congressional offices don’t even know what their own members voted on!
This was a key federal case argued for ANH-USA and other plaintiffs by Jonathan Emord and the Emord law firm. It was a remarkable seventh victory for Emord over the FDA in the area of allowable health claims for food or supplements. Unless reversed on appeal, the decision restricts the Agency’s ability to place gag orders on the emerging science behind healthy foods and dietary supplements.
In last week’s newsletter, we reported that the staff of the Senate Committee on Aging, led by Senator Kohl (D-WI), was preparing a surprise ambush of dietary supplements in a Senate hearing held last Wednesday. We were right. But we didn’t anticipate how seriously distorted the major media news stories would be.
This victory was largely due to you, our supporters, who flooded Senate offices with thousands of emails and phone calls. But the fight isn’t over yet—and our new Action Alert has all the details.
Here is The Evidence Behind our Claim That He Did.
There are lots of studies. Why is this one important? The U.S. Institute of Medicine represents the heart of the medical establishment. Congress listens to it. The President listens to it. The FDA listens to it.
An important ruling was recently handed down by the European Court of Justice in April about supplement regulation.
Many thousands of you have taken action though our website and requested your Senators not to include Waxman’s dangerous FTC power expansion measure in the Senate version of the Wall Street Reform bill. We are pleased to report that the Senate is listening!